Suppr超能文献

MPTP 注射诱导 C57BL/6 小鼠早期纹状体多巴胺能末梢丢失。

Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice.

机构信息

Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Ishikawa 920-1181, Japan.

出版信息

Neurosci Res. 2011 Apr;69(4):352-5. doi: 10.1016/j.neures.2010.12.009. Epub 2010 Dec 24.

Abstract

The molecular mechanisms underlying MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced dopaminergic (DAergic) neuronal death in vivo are still not fully understood. To investigate the selective DAergic neurotoxicity, we have developed an immunological technique to isolate DAergic synaptosomes from mouse striatal tissues using an antibody against 20 amino acid residues in the extracellular second loop of dopamine transporter (DAT). The DAT protein level in the isolated DAergic synaptosomes was markedly decreased at 16 h after a single injection of 30 mg/kg MPTP, but not in striatal homogenate and crude synaptosomes fraction. GBR-12909, a dopamine uptake inhibitor, completely reversed the MPTP-induced decrease of DAT protein in the DAergic synaptosomes. These results suggest that the isolated DAergic synaptosomes can be useful to identify mechanisms of loss of the nerve terminals.

摘要

MPTP(1-甲基-4-苯基-1,2,3,6-四氢吡啶)诱导的体内多巴胺能(DAergic)神经元死亡的分子机制尚不完全清楚。为了研究选择性 DAergic 神经毒性,我们开发了一种免疫技术,使用针对多巴胺转运体(DAT)细胞外第二环中 20 个氨基酸残基的抗体从小鼠纹状体组织中分离 DAergic 突触小体。单次注射 30mg/kg MPTP 16 小时后,分离的 DAergic 突触小体中的 DAT 蛋白水平明显下降,但纹状体匀浆和粗突触小体部分中没有下降。多巴胺摄取抑制剂 GBR-12909 完全逆转了 MPTP 诱导的 DAergic 突触小体中 DAT 蛋白的减少。这些结果表明,分离的 DAergic 突触小体可用于鉴定神经末梢丧失的机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验